Lmr Partners LLP Novavax Inc Put Options Transaction History

Lmr Partners LLP

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 07, 2024	SELL	$10.71 - $17.11 $4.07 Million - $6.5 Million	-380,100 Reduced 36.91%	649,600 $8.2 Million
Q2 2024 Aug 14, 2024	BUY	$3.89 - $20.97 $1.79 Million - $9.65 Million	460,400 Added 80.87%	1,029,700 $13 Million
Q1 2024 May 15, 2024	SELL	$3.76 - $6.02 $3.39 Million - $5.43 Million	-902,300 Reduced 61.31%	569,300 $2.72 Million
Q4 2023 Feb 14, 2024	SELL	$4.8 - $7.67 $2.44 Million - $3.89 Million	-507,800 Reduced 25.65%	1,471,600 $7.06 Million
Q3 2023 Nov 14, 2023	BUY	$6.81 - $9.74 $2.56 Million - $3.66 Million	375,600 Added 23.42%	1,979,400 $14.3 Million
Q2 2023 Aug 14, 2023	BUY	$6.67 - $9.52 $10.7 Million - $15.3 Million	1,603,800 New	1,603,800 $11.9 Million
Q3 2022 Nov 14, 2022	BUY	$18.2 - $76.12 $7.21 Million - $30.2 Million	396,100 New	396,100 $7.21 Million
Q4 2021 Feb 14, 2022	BUY	$134.56 - $217.97 $207 Million - $335 Million	1,534,700 New	1,534,700 $220 Million

290

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $662M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Lmr Partners LLP with notifications on news.